Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Livionex Dental Gel for Plaque and Caries in Children
NCT04368533Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Livionex CVI Topical Treatment in dental plaque and dental caries (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Changes of dental plaque at 12 months, Incidence of new dental caries at 12 months and 1 more. Started Feb 2019; status: completed.
02
Drugs
Livionex CVI Topical Treatment
03
Conditions
dental plaquedental caries
Beyond the preview
Go deeper on NCT04368533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04368533.